LAS VEGAS, Oct. 23, 2026 (GLOBE NEWSWIRE) -- (OTC: SPYR) (“SPYR” or the “Company”) today announced that it has closed the transaction under its stock purchase agreement with Ledjr AI (“Ledjr”). With ...

Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% ...

Despite Trump’s statement yesterday that billionaire Elon Musk had removed the restrictions from Starlink and Starshield that ...

Meta Platforms faces internal strife over Mark Zuckerberg's control amid restructuring negotiations, revealing the intricate ...

Uganda has barred travelers with a history of travel to neighboring Democratic Republic of the Congo (DRC) from transiting through the country to prevent the spread of Ebola, the Health Ministry said ...

BGB-58067 is a highly potent, brain-penetrant methylthioadenosine (MTA)-cooperative PRMT5 inhibitor designed to exploit the vulnerability created by MTAP deficiency. In this, the largest publicly ...

IMA402 PRAME bispecific continues to demonstrate encouraging anti-tumor activity in multiple indications, alongside a favorable safety profileIMA402 achieved a cORR of 32%, 12.5 months median DOR and ...

On Friday, jurors took just under 30 minutes to determine that Britton is a continuing threat to society.

Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% disease control rate, with similar activity ...

The Trump administration says Alaska shouldn't certify its Senate election results if the Democrat wins, citing confusion ...